HTGM - HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8th Annual SVB Leerink Global Healthcare Conference, being held in New York, NY on February 27 — March 1, 2019.
| HTG Molecular Presentation Details |
| Date: Time: Location: |
| Thursday, February 28 3:00pm Eastern Time Lotte New York Palace Hotel |
About HTG:
HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 535-7742
Email: arr@lifesciadvisors.com
Shaun McMeans
Chief Financial Officer
HTG Molecular Diagnostics
Email: smcmeans@htgmolecular.com